Regeneron Pharmaceuticals, Inc. <REGN.O>: Leerink Partners raises target price to $824 from $641
REGN•Related News
FTSE 100 set to snap six-day losing streak as miners gain
EWU•
Enovix CEO Talluri resigns; CFO Benton named interim CEO
ENVX•
Freightos names Yaron Eldad CFO effective Sept. 1
CRGO•
Jones Lang LaSalle Inc. <JLL.N>: Barclays raises target price to $401 from $368
JLL•
VF Corp director Richard Carucci acquires common shares worth $294,600
VFC•